Nanoparticulate formulation comprising a TRPA1 antagonist

• 收藏
• 分享

专利权人:

Glenmark Pharmaceuticals S.A.

发明人:

Dhuppad, Ulhas,Chaudhari, Sunil,Rajurkar, Suresh,Jain, Nilesh

申请号：

AU2014282762

公开号：

AU2014282762B2

申请日:

2014.06.20

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor ("TRPA1") antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer； a process for preparing such formulation； and its use in treating a respiratory disorder or pain in a subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/